In a recent post, I discussed the drug Xarelto (chemically known as rivaroxaban) and the competition this product is running to Boehringer-Ingelheim’s (BI) flagship product, Pradaxa (dabigatran). The introduction of Xarelto in the U.K., a product produced by Bayer and … Continued
The pharmaceutical drug Pradaxa has been associated with several serious side-effects causing patients, doctors and attorneys to wonder if it should remain on the market. At present, however, Pradaxa has not been recalled. In this section you will find information about the call for a Pradaxa recall, as well as updates on side effects, active lawsuits, where to report adverse events, and more information about the drug so you can make informed decisions after discussing concerns with your doctor.
Authored by Ned McWilliams In the first twelve weeks Pradaxa was on the market, more than 300 serious adverse events were reported to the FDA. Within six months of hitting pharmacies and doctors’ sample cabinets, the number of adverse events … Continued